Answers are grounded in this paper and cite their sources.
Anthracene-bridged dinuclear rhenium complexes are reported for electrocatalytic carbon dioxide (CO 2 ) reduction to carbon monoxide (CO). Related by hindered rotation of each rhenium active site to either side of the anthracene bridge, cis and trans conformers have been isolated and characterized. Electrochemical studies reveal distinct mechanisms, whereby the cis conformer operates via cooperative bimetallic CO 2 activation and conversion and the trans conformer reduces CO 2 through well-established single-site and bimolecular pathways analogous to Re(bpy)(CO) 3 Cl. Higher turnover frequencies are observed for the cis conformer (35.3 s –1 ) relative to the trans conformer (22.9 s –1 ), with both outperforming Re(bpy)(CO) 3 Cl (11.1 s –1 ). Notably, at low applied potentials, the cis conformer does not catalyze the reductive disproportionation of CO 2 to CO and CO 3 2– in contrast to the trans conformer and mononuclear catalyst, demonstrating that the orientation of active sites and structure of the dinuclear cis complex dictate an alternative catalytic pathway. Further, UV–vis spectroelectrochemical experiments demonstrate that the anthracene bridge prevents intramolecular formation of a deactivated Re–Re-bonded dimer. Indeed, the cis conformer also avoids intermolecular Re–Re bond formation.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: